By all accounts, Marty Makary’s confirmation hearing to lead the FDA went smoothly. As an experienced surgeon at Johns Hopkins with impeccable credentials, he handled questions with ease.
But the real issue was not what the senators asked Makary—it was what they didn’t ask him that was most concerning. They sidestepped the FDA's recent, glaring failures, leaving critical issues unaddressed.


